Improving MR image quality with a multi-task model, using convolutional losses.

Journal Information

Full Title: BMC Med Imaging

Abbreviation: BMC Med Imaging

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
5/6
83.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Evidence found in paper:

"to improve the reproducibility of our approach we have made all trained models and source code openly accessible 1 https://fastmri med nyu edu/ 2 https://zenodo org/record/583096 3 https://github com/brudfors/unires4 http://www simpleitk org 5 https://pypi org/project/bm3d/ publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.; for evaluating the pelvic model we have used the publicly available gold atlas dataset [ 31 ] ( https://zenodo org/record/583096 ). availability of data and materials the fastmri dataset [ 29 30 ] ( https://fastmri med nyu edu/ ) is publically available. for evaluating the pelvic model we have used the publicly available gold atlas dataset [ 31 ] ( https://zenodo"

Evidence found in paper:

"our proposed model and source code were made publicly available.; to improve the reproducibility of our approach we have made all trained models and source code openly accessible 1 https://fastmri med nyu edu/ 2 https://zenodo org/record/583096 3 https://github com/brudfors/unires4 http://www simpleitk org 5 https://pypi org/project/bm3d/ publisher's note springer nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.; the source code used for the conclusions of this article is available on github ( https://github com/attilasimko/mri-ac )."

Evidence found in paper:

"Declarations Ethics approval and consent to participateThe pelvic model was trained and validated on an in-house dataset. The scans were captured using a GE Signa 3T PET/MR (GE Healthcare, Chicago, Illinois, United States) at the University Hospital of Umeå, Sweden. All experimental protocols were approved by the Swedish Ethical Review Authority (ethical approval Dnr: 2019-02666), and all methods were carried out in accordance with relevant guidelines and regulations. All participants were adults and their informed consent was obtained. Consent for publicationNot applicable. Competing interestsThe qualitative evaluations were performed using Hero Imaging, NONPI Medical AB, where Attila Simkó is an employee and Tommy Löfstedt, Anders Garpebring, Tufve Nyholm, and Joakim Jonsson are co-owners. Simone Ruiter and Mikael Bylund declare that they have no competing interests. Competing interests The qualitative evaluations were performed using Hero Imaging, NONPI Medical AB, where Attila Simkó is an employee and Tommy Löfstedt, Anders Garpebring, Tufve Nyholm, and Joakim Jonsson are co-owners. Simone Ruiter and Mikael Bylund declare that they have no competing interests."

Evidence found in paper:

"Funding Open access funding provided by Umea University. We are grateful for the financial support obtained from the Cancer Research Foundation in Northern Sweden (LP 18-2182, AMP 18-912, AMP 20-1014, LP 22-2319), the Västerbotten regional county, and from Karin and Krister Olsson. The computations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) at the High Performance Computing Center North (HPC2N) in Umeå, Sweden, partially funded by the Swedish Research Council through grant agreement no. 2018-05973."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025